Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques. Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions

Circulation

Volumn 99, Issue 14, 1999, Pages 1780-1787

  Badimon, Juan Jose ^a,c   Lettino, Maddalena ^a   Toschi, Vincenzo ^a   Fuster, Valentin ^a   Berrozpe, Maria ^b   Chesebro, James H ^a   Badimon, Lina ^b  

^a Cardiovasc Biol Res Laboratory   (United States)

^b CSIC   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Coronary disease; TFPI; Thrombosis; Tissue factor

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG MECHANISM; HEPARINIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS;

EID: 0033551191     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.14.1780     Document Type: Article

References (38)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med. 1992;310-318.
2. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation. 1993;87(suppl II):II-3-II-16.
3. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
4. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombolysis leading to infarction and/or sudden death. Circulation. 1985;71:699-708.
5. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J. 1983;50:127-134.
6. Leach IH, Blundell JW, Rowley JM, Turner DR. Acute ischemic lesions in death due to ischemic heart disease: an autopsy study of 333 cases of out-of-hospital death. Eur Heart J. 1995;16:1181-1185.
7. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the reactive thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
8. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz D, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
9. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
10. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
11. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrisey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91:619-622.
12. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SH, Ambrose JH, Fallon JT, Nemerson Y, Taubman M. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
13. Nemerson Y. Tissue factor and haemostasis. Blood. 1988;71:1-8.
14. Rappaport SI, Rao VM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 1992;12:1111-1121.
15. Fuster V, Fallon JT, Nemerson Y. Coronary thrombosis. Lancet. 1996; 348:S7-S10.
16. Broze GJ. Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation. Trends Cardiovasc Med. 1992;2:72-77.
17. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ. Functional significance of the Kunitz-type inhibitor domains of LACI. Nature. 1989 338;518-520.
18. Wun TC, Fretzmer K, Girard T, Miletich J, Broze GJ. Cloning and characterization of a cDNA coding for the LACI shows that it consists of three tandem Kunitz inhibitory domains. J Biol Chem. 1988;263: 6001-6004.
19. Diaz-Collier JA, Palmier MO, Kretzmer K, Bishop BF, Combs RG, Obukowicz MG, Frazier RB, Bild GS, Joy WD, Hill S, Duffin KL, Gustafson M, Junger KD, Grabner RW, Gallupi GR, Wun TC. Refold and characterization of TFPI expressed in E Coli. Thromb Haemost. 1994; 71:339-346.
20. Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition: ex vivo study in a swine model. Arteriosclerosis. 1986;6:312-320.
21. Mailhac A, Badimon JJ, Fallon JT, Fernandez-Ortiz A, Meyer B, Fuster V, Meyer B, Badimon L. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall. Circulation. 1994;23:1562-1569.
22. Meyer B, Badimon JJ, Mailhac A, Fernandez-Ortiz A, Chesebro JH, Fuster V, Badimon L. Inhibition of thrombus growth on fresh mural thrombus: targeting of optimal therapy. Circulation. 1994;90:2432-2438.
23. Fraker PM, Speck JC. Protein and cell membrane iodination with a sparingly soluble chloroamide. Biophys Biochem Res Commun. 1978;80: 849-857.
24. Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffman T. Evidence for the presence of tissue factor activity on subendothelium. Blood. 1989;73:968-975.
25. Palazon CP, Alfon J, Gaffney P, Berrozpe M, Royo T, Badimon L. Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk. Atherosclerosis. 1998;136:333-345.
26. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
27. Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539-7546.
28. Rappaport SI. The extrinsic pathway inhibitor: a regulator of TF-dependent blood coagulation. Thromb Haemost 1991:66;6-10.
29. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The LACI that inhibits the f VII-TF complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71:335-343.
30. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A., Mailhac A, Villarreal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocytederived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation. 1995;92:1565-1569.
31. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406.
32. van der Waal A, Becker A, van der Loos C, Das P. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation. 1994;89:36-45.
33. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Circulation. 1994;90: 775-778.
34. Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JL, Nielsen G, Hedner U. Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis model. Haemostasis. 1993;23(suppl 1):112-117.
35. Lindahl AK, Sandset PM, Thune-Wiiger M, Nordfang O, Sakariassen-KS. Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix. Blood Coagul Fibrinolysis. 1994;5:755-760.
36. Abendscheim DR, Meng YY, Torr-Brown S, Sobel BE. Maintenance of coronary patency after fibrinolysis with TFPI. Circulation. 1995;92: 944-949.
37. Pawashe AB, Golino P, Ambrosio G, Migliacco F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg W, Ezekowitz M. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
38. Ragni M, Cirillo P, Passucci I, Scognamiglio A, D'andrea D, Eramo N, Ezekowitz MD, Pawashe AB, Chiarello M, Golino P. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation. 1996;93:1913-1918.